Gilead Sciences is acquiring the maker of an antibody-drug conjugate for breast cancer that won accelerated Food and Drug Administration approval earlier...
LONDON — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine...
Dive Brief: Sanofi and GlaxoSmithKline, which in April joined forces to develop a coronavirus vaccine, will get up to $2.1 billion from...
Two European drug companies have secured a hefty sum from a federal government program to provide 100 million doses of a vaccine...